We only have this paper's title and publication details.
Read it at the sourceCEGT does not prolong survival in women with early-stage breast cancer.
No takes yet. Share an insight, caveat, or question.
Kissane et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: